Barrington Research Maintains DENTSPLY $45 PT, Outperform

Loading...
Loading...
Barrington Research maintained its DENTSPLY
XRAY
$45 price target and Outperform rating in a research report published today. In the report, Barrington Research states, "Management initiated fiscal 2012 guidance to a range of $2.22-2.30 per diluted share on adjusted basis. Currency exchange rates are expected to have a negative impact in 2012 on both top and bottom lines. The company cited innovation, a key driver of its results in 2011 and noted that there were several exciting new products in the pipeline." Shares of DENTSPLY closed today at $38.74, down 0.79% from Friday's market close.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsBarrington Research
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...